At a recent briefing, Petro Bagriy, President of the Association "Medicine Manufacturers of Ukraine," highlighted the robust growth in exports and the increasing share of domestically produced medications.
Key Export Statistics
-
Global Reach:
Ukraine now exports its pharmaceuticals to 73 countries, reflecting its status as a leading producer in the global medicine market. -
Year-on-Year Growth:
Exports are growing at an annual rate of 15–20%, demonstrating steady expansion and increased market penetration. -
Domestic vs. Foreign Production:
- In Packages: Up to 70% of the medicines in packages are produced in Ukraine.
- In Monetary Terms: Ukrainian-made drugs account for approximately 32–35% of the market value, while 65% of the value comes from foreign-produced medicines.
- Efforts are underway to boost the monetary share of domestic production in global trade.
Strengths of Ukraine’s Pharmaceutical Industry
Global Leader in Production
Petro Bagriy emphasized that Ukraine is a pharmaceutical state. The country’s domestic production has played a crucial role in responding to urgent health crises. For instance:
-
Covid-19 Response:
During the Covid pandemic, Ukrainian manufacturers rapidly ramped up production of antiseptics and treatments, ensuring that the nation was largely self-sufficient in fighting the epidemic. -
War-Time Production:
The industry also adapted quickly during the war, producing critical medicines such as hemostatic drugs to meet rising domestic and international demand.
Increasing Domestic Share
- Quality and Volume:
Although domestic production accounts for up to 70% of the physical volume in packages, there is an ongoing effort to increase the overall market value of Ukrainian medicines. - Innovation and Responsiveness:
The Ukrainian pharmaceutical sector has demonstrated remarkable agility, consistently increasing exports and maintaining high standards even in times of crisis.
Benefits for the Economy
- Enhanced Export Revenue:
With exports growing by 15–20% annually, the pharmaceutical industry is an increasingly important source of foreign exchange earnings for Ukraine. - Global Competitiveness:
The success in the global market positions Ukraine as a competitive player in the pharmaceutical field, encouraging further investments in R&D and production capabilities. - Public Health and National Security:
A robust domestic pharmaceutical sector not only supports public health but also reduces dependency on foreign suppliers during emergencies.
Conclusion
Ukraine’s pharmaceutical industry is on an impressive growth trajectory, exporting medicines to 73 countries and growing exports by 15–20% year over year. While up to 70% of the medicines packaged in Ukraine are domestically produced, efforts to increase their market value are ongoing. As the country continues to innovate and scale its production, Ukraine is well-positioned to further enhance its role in the global medicine market, thereby boosting its economy and ensuring better public health outcomes both at home and abroad.
The robust performance of Ukraine's pharmaceutical sector is a testament to its resilience and innovation, providing critical support during health crises and underscoring the nation’s potential as a global leader in medicine production.
